Back to today’s briefing

Story perspectives

Experts Unveil Breakthrough Gene Therapies for Duchenne DMD

3/18/2025

34 7

Summary

Story summary

At the 2025 Muscular Dystrophy Association Conference in Dallas, experts unveiled groundbreaking advancements in gene therapies for Duchenne muscular dystrophy (DMD). They stressed the urgency for better delivery systems and long-term patient monitoring, while highlighting the potential of therapies like delandistrogene moxeparvovec, tempered by ongoing safety and efficacy concerns, particularly for adults.

1 of 1

Story summary

At the 2025 Muscular Dystrophy Association Conference in Dallas, experts unveiled groundbreaking advancements in gene therapies for Duchenne muscular dystrophy (DMD). They stressed the urgency for better delivery systems and long-term patient monitoring, while highlighting the potential of therapies like delandistrogene moxeparvovec, tempered by ongoing safety and efficacy concerns, particularly for adults.